secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2025-04-25T23:59:59+00:00
Accession:  0001641172-25-006122
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 2.01, 3.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Mangoceuticals acquires Smokeless Technology IP, enters oral pouch market with 1.6M shares and royalty
--------------------------------------------------------------------------------

- Acquired IP from Smokeless Technology Corp. for 1,600,000 restricted shares of MGRX common stock and 10% royalty on gross pouch product sales.
- Appointed Tim Corkum, former Philip Morris and JUUL executive, as President of new pouch subsidiary via Consulting Agreement with Strategem Solutions for 120,000 shares and $12,500/month.
- CEO Jacob Cohen received amended employment: base salary raised to $420,000, bonus of 3,192,906 shares of M&P subsidiary stock, and increased allowances.
- Pouch market projected to exceed $37 billion by 2032; Mangoceuticals plans to leverage distribution and telemedicine platform for new product lines.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000164117225006122/0001641172-25-006122-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000164117225006122/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-006122

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer